Patents by Inventor Bei Cheng

Bei Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240206031
    Abstract: The present disclosure provides a light-emitting method and a light-emitting device facing a limited condition. The limited condition may include that a light emitted by a light source transmits through a non-display surface of a light-transmitting plate that satisfies a light-transmitting condition so that a display surface of the light-transmitting plate displays a display light that satisfies a display condition. The light-transmitting condition may include a chromaticity coordinate range corresponding to the light-transmitting plate. The display condition may include a chromaticity coordinate range of the display light. The light-emitting method may include the light source satisfying that a chromaticity coordinate range corresponding to the light source is a chromaticity coordinate range of the light source for displaying the display light, and a light color adjustment range corresponding to the light source is a spectrum adjustment range of the light source for displaying the display light.
    Type: Application
    Filed: December 5, 2023
    Publication date: June 20, 2024
    Applicant: NOVATECH CO., LTD.
    Inventors: Maurizio MOLLINELLI, Yan'an SHEN, Xiaoping ZHOU, Bei CHENG, Chuan YU, Hong SHI, Daojun ZHAN
  • Patent number: 11007207
    Abstract: Described is a method to fabricate a gold/mesoporous silica hybrid nanoparticle. According to the process, a gold nanoparticle can be conjugated onto the surface of a mesoporous silica nanoparticle to yield a photothermal stable theranostic platform, gold/mesoporous silica hybrid nanoparticle. The nanoparticles can be useful for disease detection, treatment, and monitoring.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: May 18, 2021
    Assignee: University of South Carolina
    Inventors: Peisheng Xu, Bei Cheng, Huacheng He
  • Publication number: 20160067354
    Abstract: Described is a method to fabricate a gold/mesoporous silica hybrid nanoparticle. According to the process, a gold nanoparticle can be conjugated onto the surface of a mesoporous silica nanoparticle to yield a photothermal stable theranostic platform, gold/mesoporous silica hybrid nanoparticle. The nanoparticles can be useful for disease detection, treatment, and monitoring.
    Type: Application
    Filed: August 24, 2015
    Publication date: March 10, 2016
    Inventors: Peisheng Xu, Bei Cheng, Huacheng He
  • Patent number: 8809277
    Abstract: A delivery system is described that includes a polymer network that can incorporate a therapeutic peptide for targeted delivery to a cell, e.g., a cancer cell. The polymer network can secure the therapeutic peptide via two different mechanisms. First, a polymer of the network can interact with the therapeutic peptide via charge/charge interaction to form a complex with the peptide, thereby holding the peptide within the network. Second, the polymer network can be crosslinked, providing another level of securement for holding the therapeutic peptide within the network. The two levels of securement can be reversible, and following delivery of the network to the interior of a targeted cell reversal of the securement mechanisms can release the therapeutic peptide within the cell.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: August 19, 2014
    Assignee: University of South Carolina
    Inventors: Peisheng Xu, Bindu Thapa, Bei Cheng
  • Publication number: 20130244953
    Abstract: A delivery system is described that includes a polymer network that can incorporate a therapeutic peptide for targeted delivery to a cell, e.g., a cancer cell. The polymer network can secure the therapeutic peptide via two different mechanisms. First, a polymer of the network can interact with the therapeutic peptide via charge/charge interaction to form a complex with the peptide, thereby holding the peptide within the network. Second, the polymer network can be crosslinked, providing another level of securement for holding the therapeutic peptide within the network. The two levels of securement can be reversible, and following delivery of the network to the interior of a targeted cell reversal of the securement mechanisms can release the therapeutic peptide within the cell.
    Type: Application
    Filed: September 11, 2012
    Publication date: September 19, 2013
    Inventors: Peisheng Xu, Bindu Thapa, Bei Cheng